Accutane lawsuits are on the rise. In the past two months, more than 400 Accutane claims have been filed in a New Jersey mass tort litigation. All of these cases allege that the consumption of Accutane resulted in the development of serious side effects, including:

• Inflammatory Bowel Disease (IBD)
• Crohn’s Disease
• Ulcerative Colitis

The plaintiffs have claimed that Roche Holding AG, the manufacturer of the popular acne medication, failed to adequately warn users of the serious side effects associated with the drug. Approximately 1,600 Accutane claims are currently pending in our legal system.

The recent increase in Accutane litigation is most likely due to a court ruling which established the timetable for the statue of limitations as starting at the time the injured victim discovered the association between Accutane usage and the development of a serious bowel condition.

In 2009, Roche recalled Accutane citing economic reasons as the impetus for their action. In particular, they noted the high cost of defending Accutane lawsuits as a deciding factor. The majority of Accutane lawsuits have gone in favor of the plaintiffs. Earlier this year, Roche was ordered to pay $25.16 million in damages to a patient who developed inflammatory bowel disease after taking Accutane. The condition ultimately resulted in the removal of the patient’s colon.

If you have developed a serious bowel condition from taking Accutane, the pharmaceutical injury lawyers at Hagens Berman can help you receive the compensation you deserve. We are a large national law firm with extensive experience in this complex area of law, and we will fight aggressively to ensure your rights are fully protected.

Please contact our Accutane lawyers today to schedule your free initial consultation. Hagens Berman serves clients nationwide.